|
|
 | | | |
- close
- close
- close
- close
Pharmaceuticals |
Market Intelligence Center
May 22
Comment
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Tuesday's trading session at $60.00. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $57.42...
The Economic Times
May 22
Comment
The Board of Directors of Bafna Pharmaceuticals at its meeting held on May 20, 2013 have recommended 6% dividend.
Market Intelligence Center
May 21
Comment
Auxillium Pharmaceuticals (NASDAQ: AUXL) closed Monday's trading session at $15.10. In the past year, the stock has hit a 52-week low of $13.87 and 52-week high of $29.37. Auxillium Pharmaceuticals (AUXL) stock has been showing support around...
The Hindu Business Line
May 17
Comment
Pharma major Dr Reddy’s Laboratories Ltd said the new pricing policy might impact 3-4 per cent of its finished dosage sales in the domestic market. The Department of Pharmaceuticals had...
The Economic Times
May 17
Comment
Gains in technology, FMCG and realty were offset by losses in banks, pharmaceuticals and capital goods sectors.
The Hindu Business Line
May 16
Comment
Orchid Chemicals & Pharmaceuticals has posted a loss of Rs 132.27 crore for the fourth quarter of 2012-13, compared to a net profit of Rs 20.55 crore during the previous corresponding quarter....
guardian.co.uk
May 15
Comment
Hikma Pharmaceuticals moves to avoid 'unintended purposes' for drugs amid growing European boycott on sale to the US
A drug manufacturer based in Britain has vowed to add new restrictions to sales of its products in the US after it was revealed...
Market Intelligence Center
May 15
Comment
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Tuesday's trading session at $59.00. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $57.85...
Market Intelligence Center
May 15
Comment
Auxillium Pharmaceuticals (NASDAQ: AUXL) closed Tuesday's trading session at $15.41. In the past year, the stock has hit a 52-week low of $13.87 and 52-week high of $29.37. Auxillium Pharmaceuticals (AUXL) stock has been showing support around...
FierceBiotech
May 15
Comment
Just a few weeks after bidding farewell to its longtime CEO, Cambridge, MA-based Tokai Pharmaceuticals has rounded up $35.5 million in Series E cash to push into an expanded mid-stage study of its triple-threat treatment for prostate cancer.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSISThis is a list of sub-industries in the pharmaceuticals industry, and a list of their member companies
Drug Delivery
|
|
|
Drug Manufacturers - Major
|
Drug Manufacturers - Other
Drug Related Products
Biotechnology
Companies in the Pharmaceuticals Industry (14)
|
| |||||||
